Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study

BACKGROUND: Annualized relapse rate (ARR) is used as an outcome measure in multiple sclerosis (MS) clinical trials. Previous studies demonstrated that ARR has reduced in placebo groups between 1990 and 2012. This study aimed to estimate real-world ARRs from contemporary MS clinics in the UK, in orde...

Descripción completa

Detalles Bibliográficos
Autores principales: Papathanasiou, Athanasios, Hibbert, Aimee, Tallantyre, Emma, Harding, Katharine, Selvam, Adithya Panneer, Morgan, Matthew, Quainton, Charlotte, Talaei, Maryam, Arun, Tarunya, Ingram, Gillian, Law, Graham R., Evangelou, Nikos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198787/
https://www.ncbi.nlm.nih.gov/pubmed/37208584
http://dx.doi.org/10.1007/s10072-023-06838-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198787/
https://www.ncbi.nlm.nih.gov/pubmed/37208584
http://dx.doi.org/10.1007/s10072-023-06838-1

Ejemplares similares